| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Corp Strategy &Develop
1 company
Laplume Joseph W is an EVP, Corp Strategy &Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2025 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 800 | $157.60 | $126,080.00 | -3.2% | +3.7% | - | |
| Aug 7, 2025 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 400 | $150.04 | $60,016.00 | -1.6% | +12.0% | - | |
| May 13, 2025 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 500 | $145.41 | $72,705.00 | -2.5% | +3.4% | - | |
| Feb 20, 2025 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 4,400 | $162.50 | $715,000.00 | -18.0% | -16.8% | +4.1% | |
| Aug 8, 2024 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 1,780 | $199.36 | $354,860.80 | -7.3% | +6.1% | -26.3% | |
| May 10, 2024 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 1,304 | $226.97 | $295,968.88 | -5.3% | -11.5% | -39.2% | |
| Feb 15, 2024 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 838 | $238.93 | $200,223.34 | -3.3% | -5.2% | -38.1% | |
| Nov 30, 2023 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 1,850 | $197.73 | $365,800.50 | -7.4% | +30.3% | +1.0% | |
| Nov 9, 2023 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 9,128 | $173.48 | $1,583,522.13 | -13.9% | +29.0% | +27.1% | |
| Aug 10, 2023 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 700 | $216.52 | $151,564.00 | -2.7% | -19.1% | -7.6% |